Function of multidrug resistance-associated protein 2 in acute hepatic failure rats

European Journal of Pharmacology

Volumn 546, Issue 1-3, 2006, Pages 152-160

  Yokooji, Tomoharu ^a,b   Murakami, Teruo ^b   Yumoto, Ryoko ^a   Nagai, Junya ^a   Takano, Mikihisa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

2,4 Dinitrophenyl S glutathione; CCl4 induced acute hepatic failure; Hyperbilirubinemia; Intestinal efflux; Multidrug resistance associated protein 2

Indexed keywords

2,4 DINITROPHENOL; 2,4 DINITROPHENYL S GLUTATHIONE; BILIRUBIN GLUCURONIDE; CARBON TETRACHLORIDE; GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN 2; PROBENECID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; HYPERBILIRUBINEMIA; INTESTINE; JEJUNUM; LIVER; LIVER FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; AREA UNDER CURVE; ATP-BINDING CASSETTE TRANSPORTERS; BILE; BILIRUBIN; CARBON TETRACHLORIDE; DINITROCHLOROBENZENE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HYPERBILIRUBINEMIA; ILEUM; INTESTINAL MUCOSA; INTESTINES; JEJUNUM; LIVER; LIVER FAILURE, ACUTE; MALE; ORGAN SIZE; PROBENECID; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 33748296228     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.079     Document Type: Article

References (48)

1. Ben-Ari Z., Weiss-Schmilovitz H., Sulkes J., Brown M., Bar-Nathan N., Shaharabani E., Yussim A., Shapira Z., Tur-Kaspa R., and Mor E. Serum cholestasis markers as predictors of early outcome after liver transplantation. Clin. Transplant. 18 (2004) 130-136
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
3. Chan L.M., Lowes S., and Hirst S.H. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 21 (2004) 25-51
4. Cherrington N.J., Hartley D.P., Li N., Johnson D.R., and Klaassen C.D. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J. Pharmacol. Exp. Ther. 300 (2002) 97-104
5. Dietrich C.G., Geier A., Salein N., Lammert F., Roeb E., Oude Elferink R.P., Matern S., and Gartung C. Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2. Gastroenterology 126 (2004) 1044-1053
6. Fardel O., Jigorel E., Le Vee M., and Payen L. Physiological, pharmacological and clinical features of the multidrug resistance protein 2. Biomed. Pharmacother. 59 (2005) 104-114
7. Feng G.H., Cai Y., Jia Z., Yang D.Q., Chen H., Jin H.C., Yu Q.H., Zhu W., and Wang C.X. Interventional therapy of malignant obstructive jaundice. Hepatobiliary Pancreat. Dis. Int. 2 (2003) 300-302
8. Geier A., Kim S.K., Gerloff T., Dietrich C.G., Lammert F., Karpen S.J., Stieger B., Meier P.J., Matern S., and Gartung C. Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. J. Hepatol. 37 (2002) 198-205
9. Gerk P.M., and Vore M. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J. Pharmacol. Exp. Ther. 302 (2002) 407-415
10. Giessmann T., May K., Modess C., Wegner D., Hecker U., Zschiesche M., Dazert P., Grube M., Schroeder E., Warzok R., Cascorbi I., Kroemer H.K., and Siegmund W. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. Clin. Pharmacol. Ther. 76 (2004) 192-200
11. Gotoh Y., Suzuki H., Kinoshita S., Hirohashi T., Kato Y., and Sugiyama Y. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats. J. Pharmacol. Exp. Ther. 292 (2000) 433-439
12. Hauser H., Howell K., Dawson R.M., and Bowyer D.E. Rabbit small intestinal brush border membrane preparation and lipid composition. Biochim. Biophys. Acta 602 (1980) 567-577
13. Hinchman C.A., Matsumoto H., Simmons T.W., and Ballatori N. Intrahepatic conversion of a glutathione conjugate to its mercapturic acid. Metabolism of 1-chloro-2,4-dinitrobenzene in isolated perfused rat and guinea pig livers. J. Biol. Chem. 266 (1991) 22179-22185
14. Horikawa M., Kato Y., and Sugiyama Y. Reduced gastrointestinal toxicity following inhibition of the biliary excretion of irinotecan and its metabolites by probenecid in rats. Pharm. Res. 19 (2002) 1345-1353
15. Huang Z.H., Murakami T., Okochi A., Yumoto R., Nagai J., and Takano M. Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. Eur. J. Pharmacol. 406 (2000) 453-460
16. Huang Z.H., Murakami T., Okochi A., Yumoto R., Nagai J., and Takano M. Expression and function of P-glycoprotein in rats with carbon tetrachloride-induced acute hepatic failure. J. Pharm. Pharmacol. 53 (2001) 873-881
17. Hunter J., Hirst B.H., and Simmons N.L. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm. Res. 10 (1993) 743-749
18. Inui K., Okano T., Takano M., Kitazawa S., and Hori R. A simple method for the isolation of basolateral plasma membrane vesicles from rat kidney cortex. Enzyme activities and some properties of glucose transport. Biochim. Biophys. Acta 647 (1981) 150-154
19. Jedlitschky G., Leier I., Buchholz U., Hummel-Eisenbeiss J., Burchell B., and Keppler D. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem. J. 327 (1997) 305-310
20. Kamisako T., Leier I., Cui Y., Konig J., Buchholz U., Hummel-Eisenbeiss J., and Keppler D. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology 30 (1999) 485-490
21. Keppler D., Konig J., and Buchler M. The canalicular multidrug resistance protein, cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes. Adv. Enzyme Regul. 37 (1997) 321-333
22. 4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J. Biol. Chem. 273 (1998) 16184-16191
23. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
24. Maeda S., Takano M., Okano T., Ohoka K., Inui K., and Hori R. Transport of organic cation in renal brush-border membrane from rats with renal ischemic injury. Biochim. Biophys. Acta 1150 (1993) 103-110
25. Mottino A.D., Hoffman T., Jennes L., and Vore M. Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J. Pharmacol. Exp. Ther. 293 (2000) 717-723
26. Mottino A.D., Hoffman T., Jennes L., Cao J., and Vore M. Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats. Am. J. Physiol.: Gasterointest. Liver Physiol. 80 (2001) G1261-G1273
27. Murakami T., Yumoto R., Nagai J., and Takano M. Factors affecting the expression and function of P-glycoprotein in rats: drug treatments and diseased states. Pharmazie 57 (2002) 102-107
28. Naruhashi K., Tamai I., Inoue N., Muraoka H., Sai Y., Suzuki N., and Tsuji A. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats. Antimicrob. Agents Chemother. 46 (2002) 344-349
29. Ogeturk M., Kus I., Kavakli A., Zararsiz I., Ilhan N., and Sarsilmaz M. Effects of melatonin on carbon tetrachloride-induced changes in rat serum. J. Physiol. Biochem. 60 (2004) 205-210
30. Ohoka K., Takano M., Okano T., Maeda S., Inui K., and Hori R. p-Aminohippurate transport in rat renal brush-border membranes: a potential-sensitive transport system and an anion exchanger. Biol. Pharm. Bull. 16 (1993) 395-401
31. Rao U.S., Fine R.L., and Scarborough G.A. Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem. Pharmacol. 48 (1994) 287-292
32. 4-induced hepatic injury. Drug Metab. Dispos. 31 (2003) 482-490
33. Suzuki H., and Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 12 (2000) 3-12
34. Suzuki H., and Sugiyama Y. Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition. Adv. Drug Deliv. Rev. 54 (2002) 1311-1331
35. Suzuki M., Suzuki H., Sugimoto Y., and Sugiyama Y. ABCG2 transports sulfated conjugates of steroids and xenobiotics. J. Biol. Chem. 278 (2003) 22644-22649
36. Tada S., Nakamoto N., Kameyama K., Tsunematsu S., Kumagai N., Saito H., and Ishii H. Clinical usefulness of edaravone for acute liver injury. J. Gastroenterol. Hepatol. 18 (2003) 851-857
37. Takano M., Inui K., Okano T., Saito H., and Hori R. Carrier-mediated transport systems of tetraethylammonium in rat renal brush-border and basolateral membrane vesicles. Biochim. Biophys. Acta 773 (1984) 113-124
38. Takano M., Yumoto R., and Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol. Ther. 109 (2006) 137-161
39. Tanaka Y., Kobayashi Y., Gabazza E.C., Higuchi K., Kamisako T., Kuroda M., Takeuchi K., Iwasa M., Kaito M., and Adachi Y. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am. J. Physiol.: Gasterointest. Liver Physiol. 282 (2002) G656-G662
40. Tanaka Y., Slitt A.L., Leazer T.M., Maher J.M., and Klaassen C.D. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochem. Biophys. Res. Commun. 326 (2005) 181-187
41. Terao T., Hisanaga E., Sai Y., Tamai I., and Tsuji A. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J. Pharm. Pharmacol. 48 (1996) 1083-1089
42. Toh S., Wada M., Uchiumi T., Inokuchi A., Makino Y., Horie Y., Adachi Y., Sakisaka S., and Kuwano M. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am. J. Hum. Genet. 64 (1999) 739-746
43. +/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells. J. Pharmacol. Exp. Ther. 272 (1995) 63-69
44. Uhr M., Holsboer F., and Muller M.B. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J. Neuroendocrinol. 14 (2002) 753-759
45. Williamson J.R., and Corkey B.E. Assays of intermediates of the citric acid cycle and related compounds by fluorimetric enzyme methods. In: Lowenstein L.M. (Ed). Methods in Enzymology vol. XIII (1969), Academic Press, New York, NY 434-513
46. Yokooji T., Murakami T., Ogawa K., Yumoto R., Nagai J., and Takano M. Modulation of intestinal transport of 2,4-dinitrophenyl-S-glutathione, a multidrug resistance-associated protein 2 substrate, by bilirubin treatment in rats. J. Pharm. Pharmacol. 57 (2005) 579-585
47. Yumoto R., Murakami T., and Takano M. Differential effect of acute hepatic failure on in vivo and in vitro P-glycoprotein functions in the intestine. Pharm. Res. 20 (2003) 765-771
48. Zavodnik L.B., Zavodnik I.B., Lapshina E.A., Belonovskaya E.B., Martinchik D.I., Kravchuk R.I., Bryszewska M., and Reiter R.J. Protective effects of melatonin against carbon tetrachloride hepatotoxicity in rats. Cell Biochem. Funct. 23 (2005) 353-359